Categories: Research

The recognition of Krogan, Shoichet, Manglik, and Giacomini underscores the school’s commitment to fostering groundbreaking research that addresses critical issues in health care and pharmaceutical sciences.

Marcos Contreras, PharmD ’05, MBA, transitioned from medicinal chemistry to pharmacy after an interview at UCSF School of Pharmacy. Leveraging his sterile compounding skills, he moved into nuclear pharmacy and earned an MBA, leading to his role as director of pharmacy at UC Davis Veterinary Medical...

Oni-Orisan has been instrumental in developing clinical applications that bring pharmacogenomics (PGx) directly to patient care, with a focus on equity. Tamraz leads the UCSF PGx program, advocates for accessible precision medicine in California and conducts research focused on translating PGx...

The Department of Bioengineering and Therapeutic Sciences (BTS) chair is leading a multidisciplinary team that will receive federal funding to prevent side effects before drugs go to clinical trials.

Playing to his interpersonal and technical strengths, Christopher Nowak, PharmD, PMP, Class of ‘22, says UCSF’s pharmacy curriculum has helped him thrive at AstraZeneca Rare Disease.

Department of Pharmaceutical Chemistry faculty member Aashish Manglik, MD, PhD, was celebrated as a curiosity-driven scientist in the 29th annual Byers Award Lecture, where he shared how he fulfilled a research dream in his journey from Stanford University to UCSF.

The director of the UCSF Institute for Human Genetics (IHG) is being recognized for his lab’s work investigating gene regulatory elements––their relationship to human diversity and disease and their utilization for gene therapy.

David Morris, MD, has worked with many Bay Area startups, including a spin-off from the lab of Department of Pharmaceutical Chemistry faculty member Jim Wells, PhD.